Beneficial effect of treatment with transdermal estradiol-17-β on exercise-induced angina and ST segment depression in syndrome X

International Journal of Cardiology

Volumn 54, Issue 1, 1996, Pages 13-20

  Albertsson, Per A ^a   Emanuelsson, Håkan ^a   Milsom, Ian ^b  

^a SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^b UNIVERSITY OF GOTHENBURG   (Sweden)

Author keywords

Angina pectoris; Estrogen; Syndrome X; Treatment

Indexed keywords

ESTRADIOL; PLACEBO;

ADULT; ANGINA PECTORIS; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; ELECTROCARDIOGRAM; EXERCISE; FEMALE; HEART MUSCLE ISCHEMIA; HUMAN; PRIORITY JOURNAL; ST SEGMENT DEPRESSION; SYNDROME X; TRANSDERMAL DRUG ADMINISTRATION;

EID: 0029893623     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/0167-5273(96)02560-0     Document Type: Article

References (35)

1. Glendy RE, Levine SA, White PD. Coronary disease in youth: comparison of 100 patients under 40 with 300 persons past 80. JAMA 1930; 109: 1775-1778.
2. Kemp HG, Elliot WC, Gorlin R. The anginal syndrome with normal coronary arteriography. Trans Ass Am Phys 1967; 80: 59-70.
3. Kemp HG, Kronmal RA, Vliestra RE, Frye RL. Seven year survival of patients with normal or near normal coronary arteriograms: a CASS registry study. J Am Coll Cardiol 1986; 7: 479-483.
4. Rosano G, Lindsay D, Kaski JC, Sarrel P, Poole-Wilson P. Syndrome X in women: the importance of ovarian hormones. J Am Cell Cardiol 1992; 19: 254A.
5. Opherk D, Zebe H, Weihe E et al. Reduced coronary dilatory capacity and ultrastructural changes of the myocardium in patients with angina pectoris but normal coronary arteriograms. Circulation 1981; 63: 817-825.
6. Legrand V, Hodgson JMcB, Bates ER et al. Abnormal coronary flow reserve and abnormal radionucleide exercise test in patients with normal coronary angiograms. J Am Coll Cardiol 1985; 6: 1245-1253.
7. Cannon RO, Bonow RO, Bacharach SL et al. Left ventricular dysfunction in patients with angina pectoris, normal epicardial coronary arteries, and abnormal vasodilator reserve. Circulation 1985; 71: 218-226.
8. Greenberg MA, Grose RM, Neuburger N, Silverman R, Strain JE, Cohen MV. Impaired coronary vasodilator responsiveness as a cause of lactate production during pacing-induced ischemia in patients with angina pectoris and normal coronary arteries. J Am Coll Cardiol 1987; 4: 743-751.
9. Magness RR, Rosenfeld CR. Local and systemic estradiol-17 beta; effects on uterine and systemic vasodilation. Am J Physiol 1989; 256: E536-E542.
10. Jiang C, Sarrel PM, Liday DC, Poole-Wilson PA, Collins P. Endothelium-independent relaxation of rabbit coronary artery by 17-β-oestradiol in vitro. Br J Pharmacol 1991; 104; 1033-1037.
11. Romeo F, Rosano GMC, Martuscelli E, Lombarde L, Valente A. Long-term follow up of patients initially diagnosed with syndrome X. Am J Cardiol 1993; 71: 669-673.
12. Borg G. A category scale with ratio properties for intermodal and interindividual comparisons. In: Geissler H-G, Petzold P, editors. Psychophysical Judgement and the Progress of Perception. Berlin VEB Deutscher Verlag der Wissenschaften. 1982; 25-34.
13. Sullivan JM, Vander Zwaag R, Hughes JP, Maddock V, Krotz FW, Ramanathan KB, Mirvis DM. Estrogen replacement and coronary artery disease. Effect on survival in postmenopausal women. Arch Intern Med 1990; 150: 2557-2562.
14. Bush TL, Barret-Connor E, Cowan LD et al. Cardiovascular mortality and noncontraceptive use of estrogen in women: results from the Lipid Research Clinics Program Follow-up Study. Circulation 1987; 75: 1102-1109.
15. Knopp RH. The effects of postmenopausal estrogen therapy on the incidence of atherosclerotic vascular disease. Obstet Gynecol 1988; 72: 235-305.
16. Stampfer MJ, Colditz GA, Willet WC. Postmenopausal estrogen therapy and cardiovascular disease. N Engl J Med 1991; 325: 756-762.
17. Barret-Connor E, Bush TL. Estrogen and coronary heart disease in women. JAMA 1991; 265: 1861-1867.
18. Bush TL, Fried LP, Barret-Connor E. Cholesterol, lipoproteins, and coronary heart disease in women. Clin Chem 1988; 34: 1360-1370.
19. Sullivan JM, Vander Zwaag R, Lemp GF et al. Postmenopausal estrogen use and coronary atherosclerosis. Ann Intern Med 1988; 108: 358-363.
20. Hong MK, Romm PA, Reagan K, Green CE, Rackley CE. Effects of estrogen replacement therapy on serum lipid values and angiographically defined coronary artery disease in postmenopausal women. Am J Cardiol 1992; 69: 176-178.
21. Ludmer PL, Selwyn AP, Shook TL et al. Paradoxical vasoconstriction induced by acetylcholine in atherosclerotic coronary arteries. N Engl J Med 1986; 315: 1046-1051.
22. Williams JK, Adams MR, Klopfenstein HS. Estrogen modulates responses of atherosclerotic coronary arteries. Circulation 1990; 81: 1680-1687.
23. Williams JK, Adams MR, Herrington DM, Clarkson TB. Short-term administration of estrogen and vascular responses of atherosclerotic coronary arteries. J Am Coll Cardiol 1992; 20: 452-457.
24. Giscard V, Miller VM, Vanhoutte PM. Effect of 17-β-estradiol on endothelial responses in the rabbit. J Pharmacol Exp Ther 1988; 244: 19-22.
25. Rosano GM, Sarrel PM, Poole-Wilson PA, Collins P. Beneficial effect of oestrogen on exercise-induced myocardial ischemia in women with coronary artery disease. Lancet 1993; 342: 133-136.
26. Vrients CJM, Bult H, Hitter E, Herman AG, Snoeck JP. Impaired endothelium-dependent cholinergic coronary vasodilation in patients with angina and normal coronary angiograms. J Am Coll Cardiol 1992; 19: 21-31.
27. Egashira K, Inou T, Hirooka Y, Yamada A, Urabe Y, Takeshita A. Evidence of impaired endothelium-dependent coronary vasodilation in patients with angina pectoris and normal coronary angiograms. N Engl J Med 1993; 328: 1659-1664.
28. Sarrel PM, Lindsay D, Giuseppe MA, Rosano MC, Poole-Wilson PA. Angina and normal coronary arteries in women: Gynaecologic findings. Am J Obstet Gynecol 1992; 167: 467-471.
29. Mogil JS, Sternberg WF, Kest B, Marek P, Liebeskind JC. Sex differences in the antagonism of swimstress-induced analgesia: effects of gonadectomy and estrogen replacement. Pain 1993; 53: 17-25.
30. Vaitkevicius P, Wright JG, Fley JL. Effect of estrogen replacement therapy on the ST-segment response to postural and hyperventilation stimuli. Am J Cardiol 1989; 64: 1076-1077.
31. Jaffe MD. Effect of oestrogen on post-exercise electrocardiogram. Br Heart J 1977; 38: 1299-1303.
32. Marmor A, Zeira M, Zohar S. Effects of bilateral hysterosalpingo-oophorectomy on exercise-induced ST-segment abnormalities in young women. Am J Cardiol 1993; 71: 1118-1119.
33. Sarrel PM. Ovarian hormones and the circulation. Maturitas 1990; 12: 287-298.
34. Weiner DA, Ryan TJ, McCabe CH et al. Correlations among history of angina, ST-segment response and prevalence of coronary artery disease in the Coronary Artery Surgery Study (CASS). N Engl J Med 1979; 301: 230-235.
35. Camici PG, Gistri R, Lorenzoni R et al. Coronary reserve and exercise ECG in patients with chest pain and normal coronary angiograms. Circulation 1992; 86: 179-186.